Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Aller GS"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Van Aller GS; Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Graves AP; Department of Platform Technology and Science, GlaxoSmithKline, Collegeville, PA 19426, USA., Elkins PA; Department of Platform Technology and Science, GlaxoSmithKline, Collegeville, PA 19426, USA., Bonnette WG; Department of Platform Technology and Science, GlaxoSmithKline, Collegeville, PA 19426, USA., McDevitt PJ; Department of Platform Technology and Science, GlaxoSmithKline, Collegeville, PA 19426, USA., Zappacosta F; Department of Platform Technology and Science, GlaxoSmithKline, Collegeville, PA 19426, USA., Annan RS; Department of Platform Technology and Science, GlaxoSmithKline, Collegeville, PA 19426, USA., Dean TW; Department of Platform Technology and Science, GlaxoSmithKline, Collegeville, PA 19426, USA., Su DS; Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Carpenter CL; Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Mohammad HP; Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Kruger RG; Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline, Collegeville, PA 19426, USA. Electronic address: ryan.g.kruger@gsk.com.
Publikováno v:
Structure (London, England : 1993) [Structure] 2016 May 03; Vol. 24 (5), pp. 774-781. Date of Electronic Publication: 2016 Apr 07.
Autor:
Mohammad HP; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Smitheman KN; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Kamat CD; Oncology Department, Johns Hopkins University, Baltimore, MD 21231, USA., Soong D; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Federowicz KE; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Van Aller GS; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Schneck JL; Platform Technology and Sciences, GlaxoSmithKline, Collegeville, PA 19426, USA., Carson JD; Platform Technology and Sciences, GlaxoSmithKline, Collegeville, PA 19426, USA., Liu Y; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Butticello M; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Bonnette WG; Platform Technology and Sciences, GlaxoSmithKline, Collegeville, PA 19426, USA., Gorman SA; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Degenhardt Y; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Bai Y; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., McCabe MT; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Pappalardi MB; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Kasparec J; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Tian X; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., McNulty KC; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Rouse M; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., McDevitt P; Platform Technology and Sciences, GlaxoSmithKline, Collegeville, PA 19426, USA., Ho T; Platform Technology and Sciences, GlaxoSmithKline, Collegeville, PA 19426, USA., Crouthamel M; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Hart TK; Safety Assessment Department, GlaxoSmithKline, Upper Merion, PA 19406, USA., Concha NO; Platform Technology and Sciences, GlaxoSmithKline, Collegeville, PA 19426, USA., McHugh CF; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Miller WH; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Dhanak D; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Tummino PJ; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Carpenter CL; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Johnson NW; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA., Hann CL; Oncology Department, Johns Hopkins University, Baltimore, MD 21231, USA., Kruger RG; Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA 19426, USA. Electronic address: ryan.g.kruger@gsk.com.
Publikováno v:
Cancer cell [Cancer Cell] 2015 Jul 13; Vol. 28 (1), pp. 57-69.
Autor:
Mazur PK; 1] Department of Pediatrics, Stanford University School of Medicine, California 94305, USA [2] Department of Genetics, Stanford University School of Medicine, California 94305, USA [3]., Reynoird N; 1] Department of Biology, Stanford University, California 94305, USA [2]., Khatri P; Institute for Immunity, Transplantation and Infection, and Department of Medicine, Stanford University School of Medicine, California 94305, USA., Jansen PW; Department of Molecular Cancer Research and Department of Medical Oncology, University Medical Center Utrecht, 3508 AB Utrecht, The Netherlands., Wilkinson AW; Department of Biology, Stanford University, California 94305, USA., Liu S; Epigenetics Program and Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA., Barbash O; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania 19426 USA., Van Aller GS; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania 19426 USA., Huddleston M; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania 19426 USA., Dhanak D; 1] Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania 19426 USA [2] Janssen Research and Development, 1400 McKean Road, Spring House, Pennsylvania 19477, USA (D.D.); Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University, 6525GA Nijmegen, The Netherlands (M.V.)., Tummino PJ; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania 19426 USA., Kruger RG; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania 19426 USA., Garcia BA; Epigenetics Program and Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA., Butte AJ; 1] Department of Pediatrics, Stanford University School of Medicine, California 94305, USA [2] Department of Genetics, Stanford University School of Medicine, California 94305, USA., Vermeulen M; 1] Department of Molecular Cancer Research and Department of Medical Oncology, University Medical Center Utrecht, 3508 AB Utrecht, The Netherlands [2] Janssen Research and Development, 1400 McKean Road, Spring House, Pennsylvania 19477, USA (D.D.); Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University, 6525GA Nijmegen, The Netherlands (M.V.)., Sage J; 1] Department of Pediatrics, Stanford University School of Medicine, California 94305, USA [2] Department of Genetics, Stanford University School of Medicine, California 94305, USA [3]., Gozani O; 1] Department of Biology, Stanford University, California 94305, USA [2].
Publikováno v:
Nature [Nature] 2014 Jun 12; Vol. 510 (7504), pp. 283-7. Date of Electronic Publication: 2014 May 21.
Autor:
Van Aller GS; Cancer Epigenetics Discovery Performance Unit, Cancer Research, Oncology R&D and ‡Platform Technology and Sciences, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania 19426, United States., Pappalardi MB, Ott HM, Diaz E, Brandt M, Schwartz BJ, Miller WH, Dhanak D, McCabe MT, Verma SK, Creasy CL, Tummino PJ, Kruger RG
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2014 Mar 21; Vol. 9 (3), pp. 622-9. Date of Electronic Publication: 2013 Dec 31.
Autor:
Béguelin W; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA., Popovic R, Teater M, Jiang Y, Bunting KL, Rosen M, Shen H, Yang SN, Wang L, Ezponda T, Martinez-Garcia E, Zhang H, Zheng Y, Verma SK, McCabe MT, Ott HM, Van Aller GS, Kruger RG, Liu Y, McHugh CF, Scott DW, Chung YR, Kelleher N, Shaknovich R, Creasy CL, Gascoyne RD, Wong KK, Cerchietti L, Levine RL, Abdel-Wahab O, Licht JD, Elemento O, Melnick AM
Publikováno v:
Cancer cell [Cancer Cell] 2013 May 13; Vol. 23 (5), pp. 677-92.
Autor:
McCabe MT; Cancer Epigenetics Discovery Performance Unit, Cancer Research, Oncology R&D, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania 19426, USA., Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS, Liu Y, Graves AP, Della Pietra A 3rd, Diaz E, LaFrance LV, Mellinger M, Duquenne C, Tian X, Kruger RG, McHugh CF, Brandt M, Miller WH, Dhanak D, Verma SK, Tummino PJ, Creasy CL
Publikováno v:
Nature [Nature] 2012 Dec 06; Vol. 492 (7427), pp. 108-12. Date of Electronic Publication: 2012 Oct 10.